Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
KOITO take-private acquisition of Cepton
We are advising KOITO on the transaction
VF $1.5 billion sale of Supreme to EssilorLuxottica
We are advising VF on the transaction
Cleveland-Cliffs $2.5 billion acquisition of Stelco Holdings
We are advising Cleveland-Cliffs on the acquisition
Millicom tender offer by Atlas Luxco
We are advising Millicom’s independent committee on the tender offer
Airbus potential acquisition of certain Spirit AeroSystems activities
We are advising Airbus on the transaction
Nokia $2.3 billion acquisition of Infinera
We are advising Centerview Partners as financial adviser to Infinera
bitFlyer section 363 purchase of FTX Japan
We are advising bitFlyer on the acquisition through a section 363 sale
Nextracker acquisition of Ojjo
We are advising Nextracker on the acquisition
AssetMark strategic alliance with Morningstar and related acquisition of assets
We are advising AssetMark on the strategic alliance and acquisition of assets from Morningstar’s TAMP business